Xalkori (crizotinib)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Xalkori (crizotinib), covering 2015-03-30 to 2015-03-30. Get the full timeline:
Most recent: Clinical Trial Update: A Study Of Combined C- MET Inhibitor And PAN-HER Inhibitor (PF-02341066 And PF-00299804) In Patients With Non- Small Cell Lung Cancer [Phase 1]